Precision BioSciences, Inc. Common Stock (DTIL)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Precision BioSciences, Inc. Common Stock (DTIL) is listed on Nasdaq, where it has traded since March 28, 2019.
- Listed On
- Nasdaq
- Listed Since
- March 28, 2019
- Employees
- 67
- Market Cap
- $172M
About Precision BioSciences, Inc. Common Stock
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 92 institutions reported holding DTIL, with 17.7 million shares worth $138.9 million in aggregate. The largest reported holder was Aberdeen Group, with 2.2 million shares worth $17.5 million. Of the 5 largest holders listed below, 3 added shares, 1 reduced its position and 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Aberdeen Group | 2,230,178 | $18M | Unchanged |
| Bleichroeder | 2,018,190 | $16M | Added 21.39% |
| Vanguard | 1,455,442 | $11M | Added 35.11% |
| Octagon Capital Advisors | 1,350,000 | $11M | Reduced 39.64% |
| Boothbay Fund Management | 1,346,004 | $11M | Added 26.26% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is DTIL?
Precision BioSciences, Inc. Common Stock (DTIL) is listed on Nasdaq, where it has traded since March 28, 2019.
Who are the largest institutional holders of DTIL?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of DTIL were Aberdeen Group, Bleichroeder and Vanguard.
How many institutions own DTIL?
92 institutions reported a position in DTIL for the quarter ended June 30, 2026, worth $138.9 million in total.
Did institutions buy or sell DTIL last quarter?
Of the 5 largest reported holders, 3 added shares, 1 reduced its position and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for DTIL.
Every reported institutional holder, plus insider and congressional trades in DTIL, on SentiSense.